New Study Finds 100% Correlation Between Rapid Antigen Test Results and Culturable Virus Levels

Researchers have been studying the question of whether rapid antigen tests are a good indicator of contagiousness, or infectiousness, when it comes to the SARS-CoV-2 virus.

Hawaii News Now | Hawaii-Made Rapid COVID Test Gets Emergency FDA Approval

Hawaii News Now visited Oceanit office to interview the ASSURE team about the recent US FDA Emergency Use Authorization for the ASSURE-100 Rapid COVID-19 test

KITV4 | Oceanit Gets Emergency Clearance for Rapid COVID-19 Tests

KITV4 Island News visited Oceanit’s offices and labs yesterday to speak with Oceanit CEO, Dr. Patrick Sullivan about the newly authorized ASSURE-100 Rapid COVID-19 Test.

HPR | FDA Approves Emergency Use for First Rapid COVID-19 Test Developed in Hawaiʻi

Oceanit CEO, Dr. Patrick Sullivan joined Hawaii Public Radio host, Catherine Cruz to discuss the ASSURE-100 Rapid COVID-19 Test. Their ten minute discussion covered the research & development that went into ASSURE-100, the FDA EUA process, and what comes next.

Oceanit ASSURE-100 Dexter Poon

PRESS RELEASE | Oceanit Receives FDA Emergency Use Authorization for ASSURE-100 Rapid COVID-19 Tests

Oceanit receives U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the ASSURE-100 rapid antigen test for detection of COVID-19.

JAMA Forum | FDA’s Policy Changes for COVID-19 At-Home Diagnostics—Implications for Addressing Other Infectious Diseases and Future Pandemics

In an article from December 23rd, 2021, Scott Gottlieb, MD from the American Enterprise Institute in Washington, DC discusses how the most enduring technological innovation of the pandemic so far may be the advent of accurate diagnostic tests

NYTimes Opinion | Rapid Tests Are the Answer to Living With Covid-19

On Friday, October 1st, Michael J. Mina, professor of epidemiology and immunology & infectious diseases at the Harvard T.H. Chan School of Public Health, and Steven Phillips, vice president of science and strategy at the Covid Collaborative, contributed a guest essay to the New York Times titled, ‘Rapid Tests Are the Answer to Living With Covid-19’.

Testing Surveillance Protocols for Schools

As schools across the country reconvene, administrators are grappling with holding classes in the face of the Delta variant of COVID-19. Coronavirus infections are expected to trend upward, but the New York Times writes that Surveillance may hold the key to keeping the numbers manageable.

IN THE NEWS | Testing Still Critical As Travel Opens Up in Hawaii

“We know at least 40% to 50% of individuals are asymptomatic positive, so how are those individuals going to know whether they have the disease or not?” Dr. Scott Miscovich of Hawaii’s Premier Medical Group said. “That’s why you still need to have a large amount of surveillance testing available, while you’re pushing your vaccine rates up at the same time.”

Oceanit ASSURE-100 Dexter Poon

IN THE NEWS | Oceanit’s ASSURE-100 in Honolulu Civil Beat

Oceanit recently spoke with journalist, Eleni Avendaño, about the ongoing trials and development of ASSURE rapid tests. Oceanit’s ASSURE is currently in clinical trials in multiple locations as the rapid tests advance towards submission to the U.S. FDA for Emergency Use Authorization (EUA).